Investors
Press Releases
Press releases issued by Palatin are accessible below. These press releases contain additional information about our business, clinical trial developments, research and development activities, financial achievements, and strategic partnerships.
Found 331 Results
Palatin Announces Initiation of Patient Recruitment for Phase 2 Clinical Study Evaluating Oral PL8177 for Treatment of Ulcerative Colitis
September 8, 2022
Palatin Announces Intent to Effect Reverse Stock Split
August 19, 2022
Palatin Reports Positive Interim Analysis in Phase 3 Pivotal Study of PL9643 in Patients with Dry Eye Disease
August 16, 2022
Palatin Announces Preliminary Fourth Quarter Vyleesi® Net Product Revenue Increased 225% Over Prior Quarter
July 26, 2022
Palatin Reports Third Quarter Fiscal Year 2022 Financial Results and Provides Corporate Update
May 17, 2022
Palatin Announces $15 Million Private Placement of Convertible Redeemable Preferred Stock
May 12, 2022
Palatin to Report Third Quarter, Fiscal Year 2022 Results; Teleconference and Webcast to be held on May 17, 2022
May 11, 2022
Palatin to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2022 Annual Conference
May 2, 2022
Page 10 of 34